STAT3 and neoplasm: Unlike PINK1, the downstream Parkin has been reported to inhibit tumor angiogenesis through ubiquitination degradation of HIF-1α at lysine 477 [145], and inhibiting JAK2/STAT3/VEGF pathways in osteosarcoma [146].